Device Trial Radar · NCT02143284
A Study of EndoChoice's Upper&Lower Endoscopic Systems Utilizing a Full Spectrum Optical Technology
Last checked: Nov 19, 2026Latest source record: Nov 3, 2016 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
30
Actual
Start
May 2014
Primary completion
Jan 2015
Study completion Jan 2015
Sponsor
- Lead sponsor
- EndoChoice Innovation Center, Ltd.Not on our public-company list
- Sponsor type
- Industry
- First posted
- May 21, 2014
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Diagnostic
- Who can join
- All sexes, from 18 years, up to 70 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
EndoChoice's FUSE System enables a wider view range via 1-2 additional cameras (depending on the model). These optical properties are to be examined and reviewed in this trial (mainly usability and safety)
Conditions
- Gastrointestinal Diseases
Interventions
Endoscopy exploratory single arm (EndoChoice FUSE(TM) System)Device
The investigational device will be applied in otherwise standard procedures (upper and lower Gastrointestinal tract endoscopy)
Primary outcomes
What the sponsor says the trial is designed to measure.
- Performance, usability and ease of useTime frame: 1 Year
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Rambam medical center
Haifa, Israel, Israel
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.